Fig. 1From: New approaches to symptomatic treatments for Alzheimer’s diseaseNumber of cognitive enhancing agents for Alzheimer’s disease in Phase 2 and Phase 3 clinical trials 2016–2020 [5, 25,26,27,28]Back to article page